Akumin Inc. provides outpatient diagnostic imaging services in the United States.
+ 1 more risk
Fair value with concerning outlook.
Share Price & News
How has Akumin's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AKU's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: AKU underperformed the Canadian Healthcare industry which returned -41.7% over the past year.
Return vs Market: AKU underperformed the Canadian Market which returned -25.3% over the past year.
Price Volatility Vs. Market
How volatile is Akumin's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StHow Does Akumin's (TSE:AKU) P/E Compare To Its Industry, After The Share Price Drop?
3 weeks ago | Simply Wall StDid Changing Sentiment Drive Akumin's (TSE:AKU) Share Price Down By 11%?
1 month ago | Simply Wall StCould Akumin Inc.'s (TSE:AKU) Investor Composition Influence The Stock Price?
Is Akumin undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: AKU (CA$2.3) is trading below our estimate of fair value (CA$7.9)
Significantly Below Fair Value: AKU is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: AKU is poor value based on its PE Ratio (19.5x) compared to the Healthcare industry average (19.3x).
PE vs Market: AKU is poor value based on its PE Ratio (19.5x) compared to the Canadian market (10.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AKU's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AKU is good value based on its PB Ratio (0.8x) compared to the CA Healthcare industry average (1.8x).
How is Akumin forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if AKU's forecast earnings growth is above the savings rate (1.4%).
Earnings vs Market: Insufficient data to determine if AKU's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AKU's revenue (17.3% per year) is forecast to grow faster than the Canadian market (3.9% per year).
High Growth Revenue: AKU's revenue (17.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AKU's Return on Equity is forecast to be high in 3 years time
How has Akumin performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AKU has a large one-off loss of $6.0M impacting its September 30 2019 financial results.
Growing Profit Margin: AKU's current net profit margins (2.5%) are lower than last year (3.7%).
Past Earnings Growth Analysis
Earnings Trend: AKU has become profitable over the past 5 years, growing earnings by 54.5% per year.
Accelerating Growth: AKU's earnings growth over the past year (0.6%) is below its 5-year average (54.5% per year).
Earnings vs Industry: AKU earnings growth over the past year (0.6%) underperformed the Healthcare industry 2.7%.
Return on Equity
High ROE: AKU's Return on Equity (5.4%) is considered low.
How is Akumin's financial position?
Financial Position Analysis
Short Term Liabilities: AKU's short term assets ($95.9M) exceed its short term liabilities ($38.1M).
Long Term Liabilities: AKU's short term assets ($95.9M) do not cover its long term liabilities ($461.0M).
Debt to Equity History and Analysis
Debt Level: AKU's debt to equity ratio (233.3%) is considered high.
Reducing Debt: Insufficient data to determine if AKU's debt to equity ratio has reduced over the past 5 years.
Inventory Level: AKU has a high level of physical assets or inventory.
Debt Coverage by Assets: AKU's debt is not covered by short term assets (assets are 0.3x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AKU is profitable, therefore cash runway is not a concern.
Forecast Cash Runway: AKU is profitable, therefore cash runway is not a concern.
What is Akumin's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AKU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate AKU's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AKU's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AKU's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AKU's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Riadh Zine Zine-El-Abidine (47yo)
Mr. Riadh Zine-El-Abidine also known as Riadh Zine, serves as Chief Executive Officer and President at Akumin Inc. Mr. Zine serves as President and Chief Executive Officer of Elite Imaging Inc. Mr. Zine is ...
CEO Compensation Analysis
Compensation vs Market: Riadh Zine's total compensation ($USD2.44M) is above average for companies of similar size in the Canadian market ($USD157.44K).
Compensation vs Earnings: Riadh Zine's compensation has been consistent with company performance over the past year.
|President||no data||US$2.44m||6.37% $10.7m|
|CFO & Corporate Secretary||4.5yrs||US$704.66k||0.77% $1.3m|
|Executive VP & COO||5.42yrs||US$1.15m||1.16% $1.9m|
|Senior Vice President||no data||US$795.01k||1.83% $3.1m|
|Senior Vice President||3.17yrs||US$989.12k||0.13% $222.5k|
|Senior VP & General Counsel||no data||no data||0.072% $120.2k|
|Chief Compliance Officer||no data||no data||no data|
|Vice President of Human Resources||no data||no data||0.00062% $1.0k|
|Corporate Controller||no data||no data||0.043% $72.0k|
|Chief Revenue Officer of Akumin Corp||no data||no data||0.015% $25.8k|
Experienced Management: AKU's management team is considered experienced (4.5 years average tenure).
|President||no data||US$2.44m||6.37% $10.7m|
|Chairman||no data||US$169.04k||10.33% $17.3m|
|Independent Director||2.58yrs||US$177.82k||2.73% $4.6m|
|Independent Director||3yrs||US$185.32k||0.024% $40.4k|
|Lead Director||no data||US$195.32k||0.024% $40.4k|
Experienced Board: AKU's board of directors are considered experienced (3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.6%.
Akumin Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Akumin Inc.
- Ticker: AKU
- Exchange: TSX
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: CA$167.618m
- Shares outstanding: 69.84m
- Website: https://www.akumin.com
Number of Employees
- Akumin Inc.
- 151 Bloor Street West
- Suite 603
- M5S 1S4
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|AKU||TSX (The Toronto Stock Exchange)||Yes||Common Shares||CA||CAD||Dec 2017|
|AKMN.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Dec 2017|
Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2018, the company operated 95 imaging centers located in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures. The company provides a range of medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, radiology, arthrography, biopsy, and other diagnostic or interventional radiology procedures; and online medical bill payment services. Akumin Inc. is headquartered in Toronto, Canada.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/03/28 04:46|
|End of Day Share Price||2020/03/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.